At initial stages of neoplastic disease, evidence suggest that TGFβ acts as a tumor suppressor, while at the later stages of cancer, it can promote invasiveness and metastasis of different carcinomas including breast [32,49]. This evidence concerns the gene TGFB1 and cancer.